Lerimazoline
Lerimazoline is a selective 5-HT1D receptor agonist with Ki values of 72 and 3480 nM for h5-HT1D and h5-HT1B. Lerimazoline inhibits Forskolin (HY-15371)-stimulated cAMP production and induces contractions in rabbit saphenous vein preparations. Lerimazoline can be used for the research of migraine.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 54765-26-3
- Formel: C13H18N2
- Molecular Weight:202.30
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle 5-HT Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
5-HT1D Receptor 72 nM (Ki) |
5-HT1B Receptor 3480 nM (Ki) |
Lerimazoline (Compound 29) (0.1-1 μM; 60 min) binds to human h5-HT1B receptors with a Ki of 3480 nM[1].
Lerimazoline (0.1-1 μM; 60 min) binds to human h5-HT1D receptors with a Ki of 72 nM, displaying 48-fold selectivity for h5-HT1D over h5-HT1B receptors[1].
Lerimazoline (1-10 μM; 30 min) inhibits Forskolin (HY-15371)-stimulated cAMP production in transfected CHO Pro 5 cells[1].
Lerimazoline (10-10000 nM) induces contractions of rabbit saphenous vein with a 95% of the maximal effect[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 54765-26-3
-
Molecular Weight 202.30
-
Formel C13H18N2
-
SMILES
CC1=C(CC2=NCCN2)C(C)=CC(C)=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)